Abstract OBJECTIVE: To observe changes in plasma motilin (MOT) level among preterm infants after birth, to investigate the relationship between plasma motilin level and feeding intolerance (FI), and to clarify the possible risk factors. METHODS: A total of 112 preterm infants were divided into feeding tolerance (FT) group (n=59) and FI group (n=53). Their plasma MOT levels were measured by radioimmunoassay on days 1, 4, 7 and 14 of life. The clinical data of FI group were collected and subjected to multivariate logistic regression analysis. RESULTS: Compared with the FT group, the FI group showed significantly lower plasma MOT levels on days 1, 4, 7 and 14 of life (P<0.05), and there was a positive correlation between plasma MOT level and gestational age, age in days, and volume of enteral feeding in the FI group. The lower the gestational age, the longer the FI duration. There was a negative correlation between the plasma MOT level on day 1 of life and the FI duration (r=-0.913, P<0.001). Gestational age and prenatal use of glucocorticoid were protective factors for FI, while fetal distress, placental abnormality and perinatal infection were risk factors for FI. CONCLUSIONS: Change in plasma MOT level may be closely related to the development of FI in preterm infants. Early monitoring of plasma MOT level may be useful for predicting the occurrence of FI.
SUN Feng-Jie,HUANG Run-Zhong,XU Jing et al. Relationship between plasma motilin level and feeding intolerance in preterm infants[J]. CJCP, 2013, 15(4): 249-253.
SUN Feng-Jie,HUANG Run-Zhong,XU Jing et al. Relationship between plasma motilin level and feeding intolerance in preterm infants[J]. CJCP, 2013, 15(4): 249-253.
［3］Clark RH, Wagner CL, Merritt RJ, Bloom BT, Neu J, Young TE, et al. Nutrition in the neonatal intensive care unit：how do we reduce the incidence of extrauterine growth restriction?［J］. J Perinatol, 2003, 23(4): 337-344.
［4］Savino F, Grassino EC, Fissore MF, Guidi C, Liguori SA, Silvestro L, et al. Ghrelin, motilin, insulin concentration in healthy infants in the first months of life: relation to fasting time and anthropometry［J］.Clin Endocrinol(Oxf), 2006, 65(2): 158-162.
［8］Savino F, Grassino EC, Guidi C, Oggero R, Silvestro L, Miniero R. Ghrelin and motilin concentration in colicky infants［J］. Acta Paediatr, 2006, 95(6): 738-741.
［9］Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, et al. Receptor for motilin identified in the human gastrointestinal system［J］.Science, 1999, 284(5423): 2184-2188.
［10］Zhang H, Yan Y, Shi R, Lin Z, Wang M, Lin L. Correlation of gut hormones with irritable bowel syndrome［J］. Digestion, 2008, 78(2-3): 72-76.
［12］Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus［J］.Endocr Rev, 2006, 27(2): 141-169.
［13］Bryan SM, Hindmarsh PC. Normal and abnormal fetal growth［J］. Horm Res, 2006, 65(Suppl 3): 19-27.
［14］Costalos C, Gounaris A, Sevastiadou S, Hatzistamatiou Z, Theodoraki M, Alexiou EN, et al. The effect of antenatal corticosteroids on gut peptides of preterm infants—a matched group comparison: corticosteroids and gut development［J］. Early Hum Dev, 2003, 74(2): 83-88.
［15］Aly H, Abdel-Hady H, Khashaba M, El-Badry N. Erythromycin and feeding intolerance in premature infants: a randomized trial［J］.J Perinatol, 2007, 27(1): 39-43.
［16］Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants［J］. Cochrane Database Syst Rev, 2008, 16 (3): 1815-1817.
［17］Luiking YC, Akkermans LM, Peeters TL, Cnossen PJ, Nieuwenhuijs VB, Vanberge-Henegouwen GP. Effects of motilin on human interdigestive gastrointestinal and gallbladder motility, and involvement of 5HT3 receptors［J］. Neurogastroenterol Motil, 2002, 14(2): 151-159.
